MedTrace Logo

Effectiveness of a Distance Eduaction Course for Prevention in RSI/WRMD

NCT03385954 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2018-01-03

No results posted yet for this study

Summary

Repetitive Strain Injuries (RSI) or Work-Related Ostomuscular Disorders (WRMD) are musculoskeletal disorders. Nursing is one of the categories of workers most affected, due to the inherent functions they perform in their daily activities. The objective of this study is to evaluate the effects of a distance education program of prevention in RIS/WRMD on the quality of life of a nursing group.

Conditions

  • Work-related Injury

Interventions

OTHER

Intervention

The distance eduacation group course has a workload of 8 hours and will be developed over 2 weeks. It is suggested that students have a minimum of 1 hour of study per day. The course will consist of work tips, clarifications and procedures for the prevention of RIS/WRMD physical training tips to improve cardiovascular condition and, of strength and flexibility, available literature and theoretical evidence that should be answered through the knowledge acquired in the EAD course of prevention of LERDORT from the HCPA's Physiatrics and Rehabilitation Service. This Course will be available through moodle.

OTHER

Control

will receive a lecture of 30 minutes.

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Antônio C dos Santos, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-03-30
Completion
2019-03-30

Countries

  • Brazil

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385954 on ClinicalTrials.gov